Tempty Foods Reaches 100% of Crowdfunding Target on Republic Europe with 26 Days to Spare

Why It Matters

The oversubscribed round validates investor appetite for mycelium‑based proteins and provides Tempty with the runway to scale beyond Denmark, accelerating the clean‑label alternative protein market in Europe.

Key Takeaways

• Tempty hit €356.5k crowdfunding target with 26 days left
• Equity round offers 10.09% stake at €65.30 per share
• Pre‑money valuation set at €3.2 million (~$3.5 million)
• Seed round raised 5.2 million DKK (~$750k) earlier this year
• Over 250k meals sold; 100% YoY revenue growth since 2023

Pulse Analysis

Tempty Foods' successful Republic Europe campaign underscores the growing investor confidence in mycelium‑derived protein ventures. By exceeding its €355,000 target and unlocking additional funding capacity, the Danish startup demonstrates that equity crowdfunding can serve as a rapid capital source for niche food innovators. The €65.30 per share price translates to roughly $70.5, offering retail investors a low‑entry point while diluting only 10% of the company, a structure that aligns founder control with broad shareholder participation.

The financing arrives on the heels of a 5.2 million DKK seed round (about $750,000) and follows a period of robust commercial traction. Tempty has already delivered more than 250,000 meals through partners like 7‑Eleven Denmark and Coop, achieving 100% year‑on‑year revenue growth since its 2023 launch. This momentum reflects the broader shift in Europe toward clean‑label, sustainable protein sources, where mycelium is positioned not merely as a meat substitute but as a distinct category with its own culinary applications. The asset‑light model, which leverages existing distribution networks, further enhances scalability and reduces capital intensity.

Looking ahead, the newly raised capital will fuel Tempty's expansion across the Nordic region, targeting additional retail and food‑service contracts. As the mycoprotein sector gains regulatory and consumer acceptance, firms like Tempty are poised to capture market share from traditional animal‑based proteins. The successful crowdfunding round not only validates the company's growth strategy but also signals to larger institutional players that the European alternative‑protein landscape is ripe for deeper investment.